295 related articles for article (PubMed ID: 22664488)
1. Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines.
Sandhu R; Rivenbark AG; Coleman WB
Int J Oncol; 2012 Aug; 41(2):721-32. PubMed ID: 22664488
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer.
Sandhu R; Rivenbark AG; Mackler RM; Livasy CA; Coleman WB
Int J Oncol; 2014 Feb; 44(2):563-72. PubMed ID: 24297604
[TBL] [Abstract][Full Text] [Related]
3. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
Roll JD; Rivenbark AG; Jones WD; Coleman WB
Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
[TBL] [Abstract][Full Text] [Related]
4. miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.
Li W; Yi J; Zheng X; Liu S; Fu W; Ren L; Li L; Hoon DSB; Wang J; Du G
Clin Epigenetics; 2018; 10():64. PubMed ID: 29796115
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b.
Sandhu R; Rivenbark AG; Coleman WB
Breast Cancer Res Treat; 2012 Jan; 131(2):385-99. PubMed ID: 21359954
[TBL] [Abstract][Full Text] [Related]
6. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
Wu H; Zhang W; Wu Z; Liu Y; Shi Y; Gong J; Shen W; Liu C
Cell Death Dis; 2019 Jan; 10(2):48. PubMed ID: 30718452
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines.
Azizi M; Teimoori-Toolabi L; Arzanani MK; Azadmanesh K; Fard-Esfahani P; Zeinali S
Cancer Biol Ther; 2014 Apr; 15(4):419-27. PubMed ID: 24448385
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.
Nguyen T; Kuo C; Nicholl MB; Sim MS; Turner RR; Morton DL; Hoon DS
Epigenetics; 2011 Mar; 6(3):388-94. PubMed ID: 21081840
[TBL] [Abstract][Full Text] [Related]
9. Functional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4.
Ma X; Dong W; Su Z; Zhao L; Miao Y; Li N; Zhou H; Jia L
Cell Death Dis; 2016 Dec; 7(12):e2561. PubMed ID: 28032858
[TBL] [Abstract][Full Text] [Related]
10. Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis.
Robaina MC; Mazzoccoli L; Arruda VO; Reis FR; Apa AG; de Rezende LM; Klumb CE
Exp Mol Pathol; 2015 Apr; 98(2):200-7. PubMed ID: 25746661
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
Tan M; Wu J; Cai Y
Biochem Biophys Res Commun; 2013 Sep; 438(4):673-9. PubMed ID: 23939044
[TBL] [Abstract][Full Text] [Related]
12. Impact of miRNAs expression modulation on the methylation status of breast cancer stem cell-related genes.
El-Osaily HH; Ibrahim IH; Essawi ML; Salem SM
Clin Transl Oncol; 2021 Jul; 23(7):1440-1451. PubMed ID: 33433838
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
[TBL] [Abstract][Full Text] [Related]
14. [Interaction between miR-21 and DNA methylation in different breast cancer cells].
Zhang YY; Tian WP; Mei M
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May; 31(3):220-4. PubMed ID: 26387181
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation and post-transcriptional regulation of DNA methyltransferases in the ovarian carcinomas of the laying hen.
Lee JY; Jeong W; Lim W; Lim CH; Bae SM; Kim J; Bazer FW; Song G
PLoS One; 2013; 8(4):e61658. PubMed ID: 23613894
[TBL] [Abstract][Full Text] [Related]
16. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
[TBL] [Abstract][Full Text] [Related]
17. Methylation of miR-124a-1, miR-124a-2, and miR-124a-3 genes correlates with aggressive and advanced breast cancer disease.
Ben Gacem R; Ben Abdelkrim O; Ziadi S; Ben Dhiab M; Trimeche M
Tumour Biol; 2014 May; 35(5):4047-56. PubMed ID: 24375250
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-148a can regulate runt-related transcription factor 3 gene expression via modulation of DNA methyltransferase 1 in gastric cancer.
Zuo J; Xia J; Ju F; Yan J; Zhu A; Jin S; Shan T; Zhou H
Mol Cells; 2013 Apr; 35(4):313-9. PubMed ID: 23549984
[TBL] [Abstract][Full Text] [Related]
19. DNMT3B silencing suppresses migration and invasion by epigenetically promoting miR-34a in bladder cancer.
Xu K; Chen B; Li B; Li C; Zhang Y; Jiang N; Lang B
Aging (Albany NY); 2020 Nov; 12(23):23668-23683. PubMed ID: 33221743
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying aberrant expression of miR-29c in uterine leiomyoma.
Chuang TD; Khorram O
Fertil Steril; 2016 Jan; 105(1):236-45.e1. PubMed ID: 26453978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]